With global development and manufacturing sites, Catalent combines its formulation and bioavailability enhancement experience, along with delivery technologies to support the launch of more than 100 new products every year.
From its early-phase drug development centres of excellence in Nottingham, United Kingdom, Somerset, NJ, and San Diego, CA, and network of manufacturing facilities, Catalent offers partners end-to-end solutions, encompassing early drug product formulation and dose form design, through to clinical supply, commercial-scale manufacturing and lifecycle management.
For early development, these solutions include analytical, pre-formulation, and formulation technologies, and a comprehensive bioavailability enhancing technology toolkit including lipid formulation, spray drying, and hot melt extrusion. Its experience sees Catalent support the development and launch of over 100 new products every year.
By adapting for each molecule’s unique characteristics and challenges, Catalent uses its experience and a wide range of tools and technologies to create dose forms that benefit patients.
Catalent’s multi-award-winning OptiForm Solution Suite platform can assist in the development of innovative dose forms that can improve a drug’s efficacy and success. OptiForm Solution Suite is fast, flexible, and fact-based, combining the broadest selection of enabling technologies to ensure the right decisions are made at each stage of development.